Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact
Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact

Dr. Tanya Stoyanova discusses new paper “UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas” with Andrea Miyahira of PCF

June 4, 2024

Andrea Miyahira hosts Tanya Stoyanova to discuss her study, published in Cell Reports Medicine, on UCHL1 as a potential biomarker and therapeutic target for neuroendocrine carcinomas, including neuroendocrine prostate cancer. Watch below or at the link.
Link to Video with Transcript: https://www.urotoday.com/video-lectures/prostate-cancer/video/4083-uchl1-a-potential-biomarker-and-therapeutic-target-for-neuroendocrine-prostate-cancer-tanya-stoyanova.html

June 4, 2024

NewsUCLA

FacebookXPinterestRedditDeliciousWhatsappEmail
  • PreviousExciting News: Dr. Tanya Stoyanova receives Department of Defense Exploration-Hypothesis Development Award

  • NextFrancisco Solano joins Dr. Stoyanova’s lab as a PhD Candidate in Molecular Biology Interdepartmental Doctoral Program (MBIDP) at UCLA!

Related Posts ...

Exciting News: Diana Argiles Castillo passed her qualifying examination and is now a PhD candidate

News

Exciting news: Dr. Shiqin (Laura) Liu awarded grant from Department of Defense to develop immunotherapy for neuroendocrine prostate cancer.

News

Logo

ADDRESS

Los Angeles
CA 90095, USA
tstoyanova@mednet.ucla.edu

+1 (310) 825 0955

QUICK LINKS

  • UCLA
  • UCLA Health
  • Positions Available
© Stoyanova Lab. All Rights Reserved. | admin login